Published in Cancer Res on February 03, 2014
Epigenomics of clear cell renal cell carcinoma: mechanisms and potential use in molecular pathology. Chin J Cancer Res (2016) 0.91
MicroRNAs in renal cell carcinoma: a systematic review of clinical implications (Review). Oncol Rep (2015) 0.90
Novel Mad2-targeting miR-493-3p controls mitotic fidelity and cancer cells' sensitivity to paclitaxel. Oncotarget (2016) 0.77
miR-28-5p acts as a tumor suppressor in renal cell carcinoma for multiple antitumor effects by targeting RAP1B. Oncotarget (2016) 0.76
Re: miR-28-5p promotes chromosomal instability in VHL-associated cancers by inhibiting Mad2 translation. J Urol (2014) 0.75
Unconventional Functions of Mitotic Kinases in Kidney Tumorigenesis. Front Oncol (2015) 0.75
MicroRNAs in clear cell renal cell carcinoma: biological functions and applications. J Kidney Cancer VHL (2015) 0.75
miR-28 modulates exhaustive differentiation of T cells through silencing programmed cell death-1 and regulating cytokine secretion. Oncotarget (2016) 0.75
Circulating microRNAs as novel biomarkers of ALK-positive nonsmall cell lung cancer and predictors of response to crizotinib therapy. Oncotarget (2017) 0.75
Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature (2003) 5.57
High sensitivity detection of plasma proteins by multiple reaction monitoring of N-glycosites. Mol Cell Proteomics (2007) 4.72
A persistent oxygen anomaly reveals the fate of spilled methane in the deep Gulf of Mexico. Science (2011) 3.86
Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL. Nat Cell Biol (2003) 3.37
Global identification of modular cullin-RING ligase substrates. Cell (2011) 3.13
Like will to like: abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria. PLoS Pathog (2010) 2.79
Analysis of microtubule dynamic instability using a plus-end growth marker. Nat Methods (2010) 2.67
Control of nutrient-sensitive transcription programs by the unconventional prefoldin URI. Science (2003) 2.15
The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II. Mol Cell Biol (2005) 2.03
pVHL and GSK3beta are components of a primary cilium-maintenance signalling network. Nat Cell Biol (2007) 1.97
PKA phosphorylates and inactivates AMPKalpha to promote efficient lipolysis. EMBO J (2009) 1.94
pVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation. EMBO J (2008) 1.72
Activation of a HIF1alpha-PPARgamma axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy. Cell Metab (2009) 1.69
S6K1-mediated disassembly of mitochondrial URI/PP1gamma complexes activates a negative feedback program that counters S6K1 survival signaling. Mol Cell (2007) 1.66
VHL loss causes spindle misorientation and chromosome instability. Nat Cell Biol (2009) 1.65
Dietary obesity-associated Hif1α activation in adipocytes restricts fatty acid oxidation and energy expenditure via suppression of the Sirt2-NAD+ system. Genes Dev (2012) 1.59
Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer. Proc Natl Acad Sci U S A (2011) 1.59
PVHL is a regulator of glucose metabolism and insulin secretion in pancreatic beta cells. Genes Dev (2008) 1.38
Regulation of p27 degradation and S-phase progression by Ro52 RING finger protein. Mol Cell Biol (2006) 1.31
Loss of PBRM1 expression is associated with renal cell carcinoma progression. Int J Cancer (2012) 1.27
Salmonella gut invasion involves TTSS-2-dependent epithelial traversal, basolateral exit, and uptake by epithelium-sampling lamina propria phagocytes. Cell Host Microbe (2012) 1.26
URI is an oncogene amplified in ovarian cancer cells and is required for their survival. Cancer Cell (2011) 1.25
The hypoxia-inducible microRNA cluster miR-199a∼214 targets myocardial PPARδ and impairs mitochondrial fatty acid oxidation. Cell Metab (2013) 1.24
Sporadic clear cell renal cell carcinoma but not the papillary type is characterized by severely reduced frequency of primary cilia. Mod Pathol (2008) 1.23
Multitasking by pVHL in tumour suppression. Curr Opin Cell Biol (2007) 1.21
SIRT1: linking adaptive cellular responses to aging-associated changes in organismal physiology. Physiology (Bethesda) (2006) 1.20
URI-1 is required for DNA stability in C. elegans. Development (2006) 1.16
pVHL: a multipurpose adaptor protein. Sci Signal (2008) 1.16
Quantitative image analysis identifies pVHL as a key regulator of microtubule dynamic instability. J Cell Biol (2010) 1.10
Essential role of developmentally activated hypoxia-inducible factor 1alpha for cardiac morphogenesis and function. Circ Res (2008) 1.07
Priming-dependent phosphorylation and regulation of the tumor suppressor pVHL by glycogen synthase kinase 3. Mol Cell Biol (2006) 1.07
The VHL tumor suppressor: riding tandem with GSK3beta in primary cilium maintenance. Cell Cycle (2007) 1.07
p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans. EMBO Mol Med (2012) 1.04
Scientific basis for safely shutting in the Macondo Well after the April 20, 2010 Deepwater Horizon blowout. Proc Natl Acad Sci U S A (2012) 1.02
Combined VHLH and PTEN mutation causes genital tract cystadenoma and squamous metaplasia. Mol Cell Biol (2008) 1.00
BTB proteins as henchmen of Cul3-based ubiquitin ligases. Nat Cell Biol (2003) 0.99
The von Hippel-Lindau tumour suppressor: a multi-faceted inhibitor of tumourigenesis. Trends Mol Med (2004) 0.98
Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice. EMBO Mol Med (2013) 0.97
KRAS, BRAF, and TP53 deep sequencing for colorectal carcinoma patient diagnostics. J Mol Diagn (2013) 0.95
Comprehensive description of the N-glycoproteome of mouse pancreatic β-cells and human islets. J Proteome Res (2012) 0.92
A high-throughput-compatible 3D microtissue co-culture system for phenotypic RNAi screening applications. J Biomol Screen (2013) 0.92
KPNA2 is overexpressed in human and mouse endometrial cancers and promotes cellular proliferation. J Pathol (2014) 0.90
HIF1α deubiquitination by USP8 is essential for ciliogenesis in normoxia. EMBO Rep (2013) 0.88
Identification and functional characterization of pVHL-dependent cell surface proteins in renal cell carcinoma. Neoplasia (2012) 0.86
Novel prognostic markers in the serum of patients with castration-resistant prostate cancer derived from quantitative analysis of the pten conditional knockout mouse proteome. Eur Urol (2011) 0.86
Relevance of nuclear and cytoplasmic von hippel lindau protein expression for renal carcinoma progression. Am J Pathol (2003) 0.84
Identification of a gene expression signature common to distinct cancer pathways. Cancer Inform (2012) 0.83
Tumor suppressor NF2/Merlin is a microtubule stabilizer. Cancer Res (2013) 0.81
Tumor suppressor VHL functions in the control of mitotic fidelity. Cancer Res (2013) 0.79
Mechanisms of aneuploidy and its suppression by tumour suppressor proteins. Swiss Med Wkly (2011) 0.78
Longitudinal evaluation of intramyocellular lipids (IMCLs) in tibialis anterior muscle of ob/ob and ob/+ control mice using a cryogenic surface coil at 9.4 T. NMR Biomed (2011) 0.78
Genetic deletion of the long isoform of the von Hippel-Lindau tumour suppressor gene product alters microtubule dynamics. Eur J Cancer (2013) 0.77
Double-trouble in mitosis caused by von Hippel-Lindau tumor-suppressor protein inactivation. Cell Cycle (2009) 0.77
The protein tyrosine phosphatase receptor type J is regulated by the pVHL-HIF axis in clear cell renal cell carcinoma. J Pathol (2013) 0.76
In silico ionomics segregates parasitic from free-living eukaryotes. Genome Biol Evol (2013) 0.75
EPAS1/HIF-2α is a driver of mammalian pexophagy. Autophagy (2015) 0.75
Acoustic scattering from mud volcanoes and carbonate mounds. J Acoust Soc Am (2006) 0.75